{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:24:20Z","timestamp":1786112660548,"version":"build-2736575974"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Neuropharmacology"],"published-print":{"date-parts":[[1988,2]]},"DOI":"10.1097\/00002826-198802000-00011","type":"journal-article","created":{"date-parts":[[2006,10,25]],"date-time":"2006-10-25T05:17:40Z","timestamp":1161753460000},"page":"90-91","source":"Crossref","is-referenced-by-count":20,"title":["Management of Catatonic Stupor with L-Dopa"],"prefix":"10.1097","volume":"11","author":[{"given":"Vernon M.","family":"Neppe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-198802000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:28:23Z","timestamp":1785943703000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-198802000-00011"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[1988,2]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.1097\/00002826-198802000-00011","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[1988,2]]}}}